Merck and Advaxis

[Rajesh Gulati]

Working with Merck on Keytruda: Advaxis

Prostate median survivability 33.7 months
https://finance.yahoo.com/news/advaxis-announces-updated-survival-data-130010009.html

February conference schedule ASCO IASLC (lung cancer) and Immuno 360
http://ir.advaxis.com/

Corporate presentation:
https://advaxis.com/corporate-presentation/